Skip to content

Absci Corporation ABSI Asset turnover

Asset turnover at other companies

Schrodinger logo
SchrodingerSDGR
0.4×+0.1×
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
0.1×0.0×
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
0.1×0.0×
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
0.6×+0.3×
ADMA Biologics logo
ADMA BiologicsADMA
0.9×-0.2×

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.57B+341%
Enterprise value$1.57B+425%
P/S855.5×+782×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Calculated from Absci Corporation’s reported figures.

Based on trailing twelve months.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Absci Corporation's asset turnover?
Absci Corporation (ABSI) reported asset turnover of 0× in Q1 2026.
How has Absci Corporation's asset turnover changed year-over-year?
Absci Corporation's asset turnover decreased by 54.7% year-over-year, from 0× to 0×.
What is the long-term trend for Absci Corporation's asset turnover?
Over 4 years (2021 to 2025), Absci Corporation's asset turnover has grown at a -8.6% compound annual growth rate (CAGR), from 0× to 0×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.